Cancer control in Latin America (LA) and the Caribbean: 2015 update.

Touya, Diego; Louis, Jessica St.; Bukowski, Alexandra; Mendoza, Rossana Esther Ruiz; Vincent, Carmen Herrero; Blanquisett, Abraham Hernández; Strasser‐Weippl, Kathrin; Collingridge, David; Goss, Paul E.

doi:10.1200/jco.2016.34.15_suppl.e13096

Cited by 1 publication

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The increasing incidence and mortality trends in the three cities (Cali, Quito, and Costa Rica) indicate a clear necessity of better organizing access to diagnosis and treatment for this malignancy. In Latin America, fragmented structures are present with consequent unequal allocation of human and material resources in large urban centers [47,48]. Moreover, there are few hematologists in Latin America, with estimates of 0.9 hematologists per 100,000 inhabitants, while the US counts with 2.2/100,000 [49].…”

Section: Discussionmentioning

confidence: 99%

“…The number of cases was extracted, and age-adjusted specific rates were calculated for two age-groups (40)(41)(42)(43)(44)(45)(46)(47)(48)(49)(50)(51)(52)(53)(54)(55)(56)(57)(58)(59) and 60+) and to all ages. The age-adjusted specific rates were calculated using the world standard population, according to sex and for selected geographic areas with available data.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology of multiple myeloma in 17 Latin American countries: an update

et al. 2018

View full text Add to dashboard Cite

The objective of this study was to describe incidence, mortality rates, and trends for multiple myeloma (MM) in Latin America (LA), contributing to better knowledge on the epidemiology of MM in this continent. Incidence data were extracted from the International Agency for Research on Cancer (IARC), for the period 1990–2007. Mortality data were obtained for 17 countries from the World Health Organization, for the period 1995–2013. Annual average percentage change (AAPC) and 95% confidence interval (95% CI) were calculated for incidence and mortality. The average incidence rate of MM was higher in Cali (Colombia). For the age‐group over 60 years old, rates were 14.2 and 12.8 per 100,000 inhabitants for men and women, respectively. Increasing incidence trends were verified for Cali (Colombia). Mortality rates were higher among men; most countries presented increasing trends, and the highest increments were observed in Guatemala (12.5% [95% CI: 10.6; 14.5] in men; 8.8% [95% CI: 7.8; 9.8] in women), Ecuador (5.5% [95% CI: 5.0; 6.0] in men; 3.7 [95% CI: 3.1; 4.3] in women), Paraguay (2.9% [95% CI: 2.3; 3.5] in men; 3.2% [95% CI: 2.1; 4.3] in women), and Brazil (1.4% [95% CI: 1.3; 1.5] in men; 0.9% [95% CI: 0.8; 1.0] in women). Multiple myeloma presented heterogeneous incidence patterns in Cali (Colombia), Quito (Ecuador), and Costa Rica. Increasing mortality trends were verified for most Latin American countries and could be related to limited access to diagnosis and new therapies.

show abstract

Section: Discussionmentioning

confidence: 99%